Brief Research Report

Published on 28 Jun 2022

An Orthotopic Patient-Derived Xenograft (PDX) Model Allows the Analysis of Metastasis-Associated Features in Colorectal Cancer

in Cancer Molecular Targets and Therapeutics

Maria Laura De Angelis
Federica Francescangeli
Chiara Nicolazzo
Eljona Xhelili
Filippo La Torre
Lidia Colace
Alessandro Bruselles
Daniele Macchia
Sara Vitale
Paola Gazzaniga

Frontiers in Oncology

doi 10.3389/fonc.2022.869485

5,537 views
14 citations

Review

Published on 28 Jun 2022

Research Progress of Long Non-Coding RNA GAS5 in Malignant Tumors

in Cancer Molecular Targets and Therapeutics

Guohong Lin
Tianzhun Wu
Xing Gao
Ziqin He
Wenwei Nong

Frontiers in Oncology

doi 10.3389/fonc.2022.846497

4,518 views
28 citations

Original Research

Published on 28 Jun 2022

Analysis of KRAS, NRAS, and BRAF Mutations, Microsatellite Instability, and Relevant Prognosis Effects in Patients With Early Colorectal Cancer: A Cohort Study in East Asia

in Cancer Molecular Targets and Therapeutics

Yang Li
Jun Xiao
Tiancheng Zhang
Yanying Zheng
Hailin Jin

Frontiers in Oncology

doi 10.3389/fonc.2022.897548

5,329 views
9 citations

Original Research

Published on 27 Jun 2022

Clinicopathological Characteristics and Molecular Phenotypes of Primary Hepatic Lymphoma

in Cancer Molecular Targets and Therapeutics

Ai-Yan Xing
Xin-Zhe Dong
Liu-Qing Zhu
Long Liu
Dong Sun
Sen Guo

Frontiers in Oncology

doi 10.3389/fonc.2022.906245

3,098 views
4 citations

Review

Published on 27 Jun 2022

Targeting Adenylate Cyclase Family: New Concept of Targeted Cancer Therapy

in Cancer Molecular Targets and Therapeutics

Rui Guo
Tian Liu
Marzieh Dehghan Shasaltaneh
Xuan Wang
Saber Imani
QingLian Wen

Frontiers in Oncology

doi 10.3389/fonc.2022.829212

7,211 views
17 citations

Review

Published on 27 Jun 2022

The Role and Therapeutic Perspectives of Sirtuin 3 in Cancer Metabolism Reprogramming, Metastasis, and Chemoresistance

in Cancer Molecular Targets and Therapeutics

QingYi Zhao
Jing Zhou
Feng Li
Sen Guo
Liang Zhang
Jing Li
Qin Qi
Yin Shi

Frontiers in Oncology

doi 10.3389/fonc.2022.910963

5,898 views
17 citations

Original Research

Published on 24 Jun 2022

Designer Exosomes for Targeted Delivery of a Novel Therapeutic Cargo to Enhance Sorafenib-Mediated Ferroptosis in Hepatocellular Carcinoma

in Cancer Molecular Targets and Therapeutics

Xiaoju Li
Qianqian Yu
Runze Zhao
Xinyan Guo
Chenlin Liu
Kuo Zhang
Wangqian Zhang
Jinghan Liu
Jinzheng Yu
Shuning Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.898156

6,311 views
39 citations

Original Research

Published on 24 Jun 2022

Identification of Novel Tumor Antigens and the Immune Landscapes of Bladder Cancer Patients for mRNA Vaccine Development

in Cancer Molecular Targets and Therapeutics

Guixin Wang
Yukui Gao
Yanzhuo Chen
Keruo Wang
Shicheng Zhang
Gang Li

Frontiers in Oncology

doi 10.3389/fonc.2022.921711

3,693 views
8 citations

Review

Published on 23 Jun 2022

Extracellular Vesicles and Resistance to Anticancer Drugs: A Tumor Skeleton Key for Unhinging Chemotherapies

in Cancer Molecular Targets and Therapeutics

Simona Pompili
Antonella Vetuschi
Roberta Sferra
Alfredo Cappariello

Frontiers in Oncology

doi 10.3389/fonc.2022.933675

2,662 views
7 citations

Original Research

Published on 23 Jun 2022

NAMPT Inhibition Induces Neuroblastoma Cell Death and Blocks Tumor Growth

in Cancer Molecular Targets and Therapeutics

Frederic A. Vallejo
Anthony Sanchez
Branko Cuglievan
Winston M. Walters
Guillermo De Angulo
Steven Vanni
Regina M. Graham

Frontiers in Oncology

doi 10.3389/fonc.2022.883318

4,024 views
4 citations

Original Research

Published on 23 Jun 2022

NUF2 Expression Promotes Lung Adenocarcinoma Progression and Is Associated With Poor Prognosis

in Cancer Molecular Targets and Therapeutics

Feng Jiang
Xiaolu Huang
Xiang Yang
Huixin Zhou
Yumin Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.795971

3,230 views
9 citations

Review

Published on 22 Jun 2022

EV-Mediated Chemoresistance in the Tumor Microenvironment: Is NF-κB a Player?

in Cancer Molecular Targets and Therapeutics

Mauro Di Vito Nolfi
Davide Vecchiotti
Irene Flati
Daniela Verzella
Monica Di Padova
Edoardo Alesse
Daria Capece
Francesca Zazzeroni

Frontiers in Oncology

doi 10.3389/fonc.2022.933922

2,371 views
3 citations

Mini Review

Published on 22 Jun 2022

Megakaryocytes as the Regulator of the Hematopoietic Vascular Niche

in Cancer Molecular Targets and Therapeutics

Huichun Zhan
Kenneth Kaushansky

Frontiers in Oncology

doi 10.3389/fonc.2022.912060

3,237 views
9 citations

Review

Published on 22 Jun 2022

Targeting Tumour-Associated Fibroblasts in Cancers

in Cancer Molecular Targets and Therapeutics

Kairav Shah
Sanchari Basu Mallik
Praveer Gupta
Abishek Iyer

Frontiers in Oncology

doi 10.3389/fonc.2022.908156

5,256 views
14 citations

Clinical Trial

Published on 21 Jun 2022

Long-Term Safety and Efficacy of CD19 Humanized Selective CAR-T Therapy in B-ALL Patients Who Have Previously Received Murine-Based CD19 CAR-T Therapy

in Cancer Molecular Targets and Therapeutics

Yu Zhao
Jianping Zhang
Junfang Yang
Huantong Wu
Yao Chen
Nannan Li
Zhongfeng Liu
Xuan Wang
Weihua Liu
Guangji Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.884782

2,151 views
4 citations

Original Research

Published on 20 Jun 2022

Blocking ATM Attenuates SKOV3 Cell Proliferation and Migration by Disturbing OGT/OGA Expression via hsa-miR-542-5p

in Cancer Molecular Targets and Therapeutics

Ning Wang
Miaomiao Yu
Yan Fu
Zhanchuan Ma

Frontiers in Oncology

doi 10.3389/fonc.2022.839508

2,503 views
7 citations

Navigation group

Articles

An Orthotopic Patient-Derived Xenograft (PDX) Model Allows the Analysis of Metastasis-Associated Features in Colorectal Cancer

Research Progress of Long Non-Coding RNA GAS5 in Malignant Tumors

Analysis of KRAS, NRAS, and BRAF Mutations, Microsatellite Instability, and Relevant Prognosis Effects in Patients With Early Colorectal Cancer: A Cohort Study in East Asia

Clinicopathological Characteristics and Molecular Phenotypes of Primary Hepatic Lymphoma

Targeting Adenylate Cyclase Family: New Concept of Targeted Cancer Therapy

The Role and Therapeutic Perspectives of Sirtuin 3 in Cancer Metabolism Reprogramming, Metastasis, and Chemoresistance

Designer Exosomes for Targeted Delivery of a Novel Therapeutic Cargo to Enhance Sorafenib-Mediated Ferroptosis in Hepatocellular Carcinoma

Identification of Novel Tumor Antigens and the Immune Landscapes of Bladder Cancer Patients for mRNA Vaccine Development

Extracellular Vesicles and Resistance to Anticancer Drugs: A Tumor Skeleton Key for Unhinging Chemotherapies

NAMPT Inhibition Induces Neuroblastoma Cell Death and Blocks Tumor Growth

NUF2 Expression Promotes Lung Adenocarcinoma Progression and Is Associated With Poor Prognosis

EV-Mediated Chemoresistance in the Tumor Microenvironment: Is NF-κB a Player?

Megakaryocytes as the Regulator of the Hematopoietic Vascular Niche

Targeting Tumour-Associated Fibroblasts in Cancers

Long-Term Safety and Efficacy of CD19 Humanized Selective CAR-T Therapy in B-ALL Patients Who Have Previously Received Murine-Based CD19 CAR-T Therapy

Blocking ATM Attenuates SKOV3 Cell Proliferation and Migration by Disturbing OGT/OGA Expression via hsa-miR-542-5p